---
$id: https://graph.org.ai/products/commodity/51131723
$type: Product
source: UNSPSC
code: "51131723"
title: "Cloricromen"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cloricromen

**UNSPSC Code**: 51131723
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent with the molecular formula C20H26ClNO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B9454PE93C, chemically known as acetic acid, ((8-chloro-3-(2-(diethylamino)ethyl)-4-methyl-2-oxo-2h-1-benzopyran-7-yl)oxy)-, ethyl ester but generally known as cloricromen, which bears US NIH Compound Identifier 68876. European Medicines Agency schedules Cloricromen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06756MIG. The term CLORICROMEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules cloricromen in its Anatomical Therapeutic Chemical (ATC) Classification. CLORICROMEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, CLORICROMEN remains the US FDA Preferred Term for this commodity. Cloricromen bears US NLM identifiers UMLS ID C0050066 and NCI Concept Code C78091. SMILES: CLC1C2OC(=O)C(CCN(CC)CC)C(C2CCC1OCC(=O)OCC)C.

